Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases.
about
Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathyOffice immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathyAutoimmune neuromuscular disordersGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Hyperventilation-induced nystagmus in a large series of vestibular patients.Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes.Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination patternIdiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in ItalyEvidence-based treatment of chronic immune-mediated neuropathies.Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations.Novel treatment for immune neuropathies on the horizon.Intravenous immunoglobulin in the treatment of neurologic disorders.Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.Early predictive factors of disability in CIDP.Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trialNovel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop.Two years' long-term follow up in chronic inflammatory demyelinating polyradiculoneuropathy: efficacy of intravenous immunoglobulin treatment.Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.Quantitative muscle ultrasound is useful for evaluating secondary axonal degeneration in chronic inflammatory demyelinating polyneuropathy.Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP.Chronic inflammatory demyelinating polyradiculoneuropathy: search for factors associated with treatment dependence or successful withdrawal.Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.Chronic inflammatory demyelinating polyradiculoneuropathy, in an 8-year-old girl, complicated by deafness and kidney fibrosis.Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study.Novel pathomechanisms in inflammatory neuropathies.Autologous haematopoietic stem cell transplantation for neurological diseases.IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration.Muscle atrophy in chronic inflammatory demyelinating polyneuropathy: a computed tomography assessment.Nerve Ultrasound and Electrophysiology for Therapy Monitoring in Chronic Inflammatory Demyelinating Polyneuropathy.Treatment dependence in chronic inflammatory demyelinating polyradiculoneuropathy: is it related to disease phenotype or to the therapy used?
P2860
Q24186751-D668E8F3-8C2D-4C22-8BE4-2380B741091CQ28081570-4971E14D-6E74-46BF-88D5-282D852FC8D8Q28261039-E6DB2839-A1FC-49D0-95B9-7D05E973B976Q30276550-5B1D289D-1718-4B13-9AA3-DFF792A4B1CCQ30473803-1E9BE1FE-22F8-4F77-B506-A3E426FC9E6DQ34020516-0F65F8D6-93DE-4EA7-9741-D55E70708B63Q35141051-D9ECCC2B-C593-4DA5-BB3C-2B3EF74B5F78Q36172657-4AFE69C9-DBCD-4341-8D74-FEF2F7A8CE32Q37550515-CF9B9FC5-9BA2-45FC-8CA4-E427222A1C7BQ37557375-B9198181-3E0F-43DC-AEE8-1F822C333B3DQ37892641-75B2EB93-6246-4DE6-A387-1E451909A26EQ38495457-D8780F06-5785-4305-9901-F6163C8E8B33Q38599369-74050233-1579-4462-AB7B-A1C5C1ECD295Q38645214-B2A70F84-4620-4CD5-94A5-03CB89A6E18EQ38646013-F56A5362-841B-4E1D-AFF1-B2289881040BQ38711142-032E54C9-52E5-4124-96D0-622313563923Q38848521-E18834EE-2F56-417F-98A8-456695A0FDB7Q42372439-15C37883-127E-4BEF-B091-D952E50152BDQ42612036-2150B3F0-F14D-4405-A322-82BC5B8613B7Q42655915-59408E37-3064-4DBF-89BC-B55AE6C3EC64Q43729119-602CAC7D-C46E-4417-BBE8-15A746D7C39AQ44970432-F2F83B2A-2E6A-46B8-B174-5A01300F0735Q45888041-871620A4-FAEA-44D3-87AC-3EB6941F2A52Q46110662-EE02D6FC-D9E6-4635-9334-4322ADC1056BQ46887163-5C7F16E8-A8A6-4918-A95A-6CB00DE392C9Q47126672-808F4081-5A26-4DB1-998B-3ABEED7AAC15Q48136043-53E5A7FB-3CE0-4D0D-A399-0A1207D9C13CQ48172896-6272C9E3-ADF3-485A-B3BA-75518D7B9C2DQ53072665-199C9CE0-AAE4-4978-AF8F-88EFEA4F78D9Q53395405-E5695545-7B87-4D21-A3F8-D1C66EC1CD73Q54442434-077A0D7E-1152-41ED-9B22-4E95F2A0822A
P2860
Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Long term prognosis of chronic ...... ve year follow up of 38 cases.
@ast
Long term prognosis of chronic ...... ve year follow up of 38 cases.
@en
type
label
Long term prognosis of chronic ...... ve year follow up of 38 cases.
@ast
Long term prognosis of chronic ...... ve year follow up of 38 cases.
@en
prefLabel
Long term prognosis of chronic ...... ve year follow up of 38 cases.
@ast
Long term prognosis of chronic ...... ve year follow up of 38 cases.
@en
P2093
P2860
P356
P1476
Long term prognosis of chronic ...... ive year follow up of 38 cases
@en
P2093
P2860
P356
10.1136/JNNP.2005.065441
P407
P577
2006-01-01T00:00:00Z